WINDSOR JAMES BRIAN (Chief Science Officer) sold 83.3% of their position (25K shares) of TFF PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $395.0K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/9/2020ACC: 0001213900-20-041813
DirectorOfficer· Chief Science Officer
Since Oct 2019
-25K
Net shares
Net seller
$395.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
25K acquired · 50K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+25K
Price / share
$2.50
Trade value
$62.50K
% of position
500.0%
12/7/2020
5K→30K
Common Stock
Direct
Shares
−25K
Price / share
$15.80
Trade value
$395K
% of position
83.3%
12/7/2020
30K→5K
Total
Net shares
+0.00
Net value
-$332.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/7/2020 | M · Option Exercise | +25K | $2.50 | $62.50K | 500.0% | 5K | 30K |
| Common Stock Direct | 12/7/2020 | S · Sale | −25K | $15.80 | $395K | 83.3% | 30K | 5K |
| Total | +0.00 | -$332.50K | ||||||
Derivative Transactions1
Stock Options (Right to Buy)
Direct
Converts to
Common Stock
25K shares
Shares
−25K
Strike price
2.5
Held after
134.43K
Exercisable
—
12/7/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) Direct | Common Stock25K shares | 12/7/2020 | M · Option Exercise | −25K | 2.5 | — | 134.43K |